1. Home
  2. DCTH vs ACCD Comparison

DCTH vs ACCD Comparison

Compare DCTH & ACCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • ACCD
  • Stock Information
  • Founded
  • DCTH 1988
  • ACCD 2007
  • Country
  • DCTH United States
  • ACCD United States
  • Employees
  • DCTH N/A
  • ACCD N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • ACCD Business Services
  • Sector
  • DCTH Health Care
  • ACCD Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • ACCD Nasdaq
  • Market Cap
  • DCTH 305.2M
  • ACCD 286.7M
  • IPO Year
  • DCTH N/A
  • ACCD 2020
  • Fundamental
  • Price
  • DCTH $9.39
  • ACCD $3.47
  • Analyst Decision
  • DCTH Strong Buy
  • ACCD Buy
  • Analyst Count
  • DCTH 4
  • ACCD 12
  • Target Price
  • DCTH $21.50
  • ACCD $9.04
  • AVG Volume (30 Days)
  • DCTH 445.4K
  • ACCD 1.3M
  • Earning Date
  • DCTH 11-08-2024
  • ACCD 01-06-2025
  • Dividend Yield
  • DCTH N/A
  • ACCD N/A
  • EPS Growth
  • DCTH N/A
  • ACCD N/A
  • EPS
  • DCTH N/A
  • ACCD N/A
  • Revenue
  • DCTH $22,644,000.00
  • ACCD $441,028,000.00
  • Revenue This Year
  • DCTH $1,562.76
  • ACCD $15.56
  • Revenue Next Year
  • DCTH $117.72
  • ACCD $11.76
  • P/E Ratio
  • DCTH N/A
  • ACCD N/A
  • Revenue Growth
  • DCTH 945.91
  • ACCD 16.04
  • 52 Week Low
  • DCTH $2.38
  • ACCD $3.08
  • 52 Week High
  • DCTH $12.88
  • ACCD $15.36
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 40.91
  • ACCD 47.12
  • Support Level
  • DCTH $10.11
  • ACCD $3.08
  • Resistance Level
  • DCTH $12.88
  • ACCD $3.80
  • Average True Range (ATR)
  • DCTH 0.66
  • ACCD 0.17
  • MACD
  • DCTH -0.23
  • ACCD 0.05
  • Stochastic Oscillator
  • DCTH 12.75
  • ACCD 54.17

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About ACCD Accolade Inc.

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Share on Social Networks: